Sitagliptan is a potent dipeptidyl peptidase-4 (DPP-4) inhibitor used alongside diet and exercise to manage type 2 diabetes by enhancing insulin secretion and suppressing glucagon release to control hyperglycemia.… Read more
Sitagliptan is a potent dipeptidyl peptidase-4 (DPP-4) inhibitor used alongside diet and exercise to manage type 2 diabetes by enhancing insulin secretion and suppressing glucagon release to control hyperglycemia. This category provides access to high-quality Sitagliptan reference standards, including the active pharmaceutical ingredient, pharmacopeial and non-pharmacopeial impurities, and stable isotope-labelled compounds. Pharmaceutical laboratories rely on these materials for critical analytical testing, impurity profiling, and rigorous quality control protocols during drug development and stability studies. By utilizing these precise standards, researchers can ensure the accuracy of method validation and regulatory compliance when assessing the purity and degradation profile of this therapeutic agent. These compounds are essential tools for maintaining the rigorous standards required in modern pharmaceutical analysis and manufacturing.